Compared to patients in the first wave, patients in the second wave were more often obese, had more often comorbidities such as diabetes, chronic kidney disease, or neuromuscular disease, and were treated more frequently with systemic steroids, beta blocking agents, or insulin at home (Table 1). The gene discussed is INS; the disease is neuromuscular disease.